ArticleCancers2022

Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center.

Henry Hiep Vo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.